Abiopharma

🔍 BAILLY R JEFFREY (Director)

Company: UFP TECHNOLOGIES INC (UFPT)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Sold 5,771 shares of Common Stock, $.01 Par Value at $315.53 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,240.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 6,866 shares of Common Stock, $.01 Par Value at $316.58 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 374.00 | transaction_form_type: 4 | Footnotes: F2, F4
• Sold 374 shares of Common Stock, $.01 Par Value at $317.27 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F4

Footnotes:

• F1: The Price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $315.005 to $315.99, inclusive. The reporting person undertakes to provide UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
• F2: The Price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $316.01 to $316.97, inclusive. The reporting person undertakes to provide UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
• F3: The Price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $317.135 to $317.275, inclusive. The reporting person undertakes to provide UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
• F4: The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of any or all of the reported shares for purposes of Section 16 or any other purpose.
• F5: The reporting person also holds 171,200 shares of UFP Technologies, Inc. directly.